One third of antibiotic prescriptions for hospitalized patients are written with some type of error.

More than 60 medical societies have named hundreds of routine actions or tests that are unnecessary and shouldn't be done, speeding the momentum of this effort.

Dr. John Marshall reports that in patients with metastatic colorectal cancer, anti-EGFR therapy could not only prove ineffective but actually harmful, depending on their RAS mutations.

There is increasing awareness of the adverse health implications of sleep deprivation/fragmentation. Could it play a role in cancer development and progression? Dr. David Johnson offers commentary.

Microsporidiosis is an emerging transplant-associated infection, and CDC depends on astute clinicians to recognize the signs of this and other donor-derived diseases.

Healthcare today is undeniably intertwined with industry. The challenge is to keep it professional and patient-centered.

Providers must be more proactive if we are to raise national colorectal cancer screening rates.

Dr. David Kerr reports on a study providing more evidence that patients with PIK3CA-mutant colorectal cancer benefit most from adjuvant aspirin therapy, but awaits prospective trials for confirmation.

New evidence suggests that even if they seem to be in remission, patients with sleep problems are more likely to suffer disease flares.

A major pharmaceutical company plans to stop paying doctors to promote its drugs, which may help curb industry bias but could also impede physician education, says Dr. Gerald Chodak.